Prognostic classification in acute exacerbation of idiopathic pulmonary fibrosis: a multicentre retrospective cohort study

被引:0
|
作者
Takahito Suzuki
Hironao Hozumi
Koichi Miyashita
Masato Kono
Yuzo Suzuki
Masato Karayama
Kazuki Furuhashi
Hirotsugu Hasegawa
Tomoyuki Fujisawa
Noriyuki Enomoto
Yutaro Nakamura
Naoki Inui
Koshi Yokomura
Hidenori Nakamura
Takafumi Suda
机构
[1] Hamamatsu University School of Medicine,Second Division, Department of Internal Medicine
[2] Seirei Hamamatsu General Hospital,Department of Respiratory Medicine
[3] Seirei Mikatahara General Hospital,Department of Respiratory Medicine
[4] Hamamatsu University School of Medicine,Department of Clinical Pharmacology and Therapeutics
来源
Scientific Reports | / 11卷
关键词
D O I
暂无
中图分类号
学科分类号
摘要
Acute exacerbation (AE) in idiopathic pulmonary fibrosis (IPF) is a major prognostic determinant. However, evidence for its prognostic strength is mainly based on the results of small cohort studies with statistical limitations. This retrospective study, which included 108 patients with a first episode of AE-IPF, aimed to identify prognostic factors and to develop prognostic classification models. Multivariate Cox regression analysis revealed that a lower percent-predicted forced vital capacity within 12 months before AE onset (baseline %FVC) and a lower PaO2/FiO2 ratio at AE onset were independent mortality predictors. If the value of each predictor was lower than the cutoff determined by receiver-operating characteristic analysis, 1 point was assigned. Classification of patients into mild, moderate, and severe groups based on total score showed post-AE 90-day cumulative survival rates of 83.3%, 66.2%, and 22.2%, respectively (model 1: C-index 0.702). Moreover, a decision tree-based model was created with the recursive partitioning method using baseline %FVC and PaO2/FiO2 ratio at AE onset from among multivariable; accordingly, patients were classified into 3 groups with post-AE 90-day cumulative survival rates of 84.1%, 64.3%, and 24.0%, respectively (model 2: C-index 0.735). These models can guide clinicians in determining therapeutic strategies and help design future studies on AE-IPF.
引用
收藏
相关论文
共 50 条
  • [21] Prognostic Value of Serum Osteopontin in Acute Exacerbation of Idiopathic Pulmonary Fibrosis
    Gui, Xianhua
    Qiu, Xiaohua
    Xie, Miaomiao
    Tian, Yaqiong
    Min, Cao
    Huang, Mei
    Hongyan, Wu
    Chen, Tingting
    Zhang, Xin
    Chen, Jingyu
    Cao, Mengshu
    Cai, Hourong
    BIOMED RESEARCH INTERNATIONAL, 2020, 2020
  • [22] Prognostic evaluation of serum ferritin in acute exacerbation of idiopathic pulmonary fibrosis
    Enomoto, Noriyuki
    Oyama, Yoshiyuki
    Enomoto, Yasunori
    Mikamo, Masashi
    Karayama, Masato
    Hozumi, Hironao
    Suzuki, Yuzo
    Kono, Masato
    Furuhashi, Kazuki
    Fujisawa, Tomoyuki
    Inui, Naoki
    Nakamura, Yutaro
    Suda, Takafumi
    CLINICAL RESPIRATORY JOURNAL, 2018, 12 (08): : 2378 - 2389
  • [23] Prognostic value of the qSOFA in patients with acute exacerbation of idiopathic pulmonary fibrosis
    Yamazaki, Ryo
    Nishiyama, Osamu
    Yoshikawa, Kazuya
    Tohda, Yuji
    Matsumoto, Hisako
    RESPIRATORY INVESTIGATION, 2023, 61 (03) : 339 - 346
  • [24] Retrospective analysis of patients hospitalized with acute exacerbation of idiopathic pulmonary fibrosis
    Erten, Hasibe Cigdem
    Gulsen, Erdem Emre
    Fidan, Ali
    Talan, Ecem Ay
    Sen, Ahmet Cengiz
    Kiral, Nesrin
    Comert, Sevda Sener
    EURASIAN JOURNAL OF PULMONOLOGY, 2024, 26 (02) : 112 - 119
  • [25] Early tapering of corticosteroid in patients with acute exacerbation of idiopathic pulmonary fibrosis: A retrospective multi-center cohort study
    Anan, Keisuke
    Kataoka, Yuki
    Ichikado, Kazuya
    Kawamura, Kodai
    Johkoh, Takeshi
    Fujimoto, Kiminori
    Tobino, Kazunori
    Tachikawa, Ryo
    Ito, Hiroyuki
    Nakamura, Takahito
    Kishaba, Tomoo
    Inomata, Minoru
    Yamamoto, Yosuke
    RESPIROLOGY, 2023, 28 : 10 - 11
  • [26] Risk factors for acute exacerbation following bronchoalveolar lavage in patients with suspected idiopathic pulmonary fibrosis: A retrospective cohort study
    Abe, Mitsuhiro
    Tsushima, Kenji
    Ishii, Daisuke
    Shikano, Kohei
    Yoshioka, Keiichiro
    Sakayori, Masashi
    Suzuki, Masaki
    Hirasawa, Yasutaka
    Ishiwata, Tsukasa
    Kawasaki, Takeshi
    Ikari, Jun
    Terada, Jiro
    Tatsumi, Koichiro
    ADVANCES IN RESPIRATORY MEDICINE, 2021, 89 (02) : 101 - 109
  • [27] Prognostic significance of Glasgow Prognostic Score in patients with acute exacerbation of idiopathic pulmonary fibrosis
    Kang, Hye Seon
    Kim, Yong Hyun
    Kwon, Soon Seog
    Kim, Jin Woo
    EUROPEAN RESPIRATORY JOURNAL, 2017, 50
  • [28] Prognostic significance of Glasgow prognostic score in patients with acute exacerbation of idiopathic pulmonary fibrosis
    Kang, Hye S.
    Cho, Kang W.
    Kwon, Soon S.
    Kim, Yong H.
    RESPIROLOGY, 2018, 23 (02) : 206 - 212
  • [29] Retrospective Study of Effect of Fine Particulate Matter on Acute Exacerbation of Patients with Idiopathic Pulmonary Fibrosis
    Che Chun Li
    Dong Fu Shi
    Li Jia Lin
    Zhang Chun Ling
    Liu Lu
    Wu Yu Han
    Wang Kun
    Qi Hong
    BIOMEDICAL AND ENVIRONMENTAL SCIENCES, 2020, 33 (02) : 138 - +
  • [30] SYSTEMIC GLUCOCORTICOIDS PLUS CYCLOPHOSPHAMIDE FOR ACUTE EXACERBATION OF IDIOPATHIC PULMONARY FIBROSIS: A RETROSPECTIVE NATIONWIDE STUDY
    Aso, Shotaro
    Matsui, Hiroki
    Fushimi, Kiyohide
    Yasunaga, Hideo
    SARCOIDOSIS VASCULITIS AND DIFFUSE LUNG DISEASES, 2019, 36 (02) : 116 - 123